About Black Bryont Pharmaceuticals
Black Bryont Pharmaceuticals is a Healthcare company. Provision of pharmaceuticals and medical services in India. Its Indian entity Blackbryont Pharmaceuticals Private Limited reported revenue of βΉ1.57 Cr. Black Bryont Pharmaceuticals offers products and services including Branded Generics and Medicine Distribution Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Medical Services.
Company details
Quality and affordable pharmaceuticals are provided by Black Bryont Pharmaceuticals to enrich lives, focusing on branded generics for specialties like orthopedics, gynecology, and pediatrics. The company is recognized for its social responsibility in easing sufferings through affordable options and partnerships in healthcare. Achievements include serving over 1 lakh customers with expert pharmacies and more than 10 years of managerial expertise, while emphasizing fast delivery and reliable medicine supply. Operations are based in Kochi, India, with a commitment to collaboration among healthcare professionals.
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Legal Name Blackbryont Pharmaceuticals Pvt Ltd
- Date of Incorporation 30 Sep, 2009
- Jurisdiction Ernakulam, Kerala, India
- Indian entity revenue₹1.57 Cr
FY 2025 · -3% YoY
- Indian entity net profit₹10,378
FY 2025 · 0% margin
- Indian entity EBITDA₹8.8 Lakh
FY 2025 · 6% margin
Associated legal entities of Black Bryont Pharmaceuticals
Black Bryont Pharmaceuticals operates through Blackbryont Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Blackbryont Pharmaceuticals Private Limited CIN U24232KL2009PTC024806 | Active | 30 Sep 2009 | Ernakulam, Kerala | ₹1.6 Cr | 7 | View details |
Products & Services of Black Bryont Pharmaceuticals
Black Bryont Pharmaceuticals offers a comprehensive portfolio of products and services, including Branded Generics and Medicine Distribution Services.
Generic drugs are supplied by Black Bryont Pharmaceuticals for various medical specialties, including orthopedics and pediatrics.
Medicines are distributed by Black Bryont Pharmaceuticals through partnerships and delivery services to healthcare professionals and pharmacies.
Board of directors of Blackbryont Pharmaceuticals Private Limited (Black Bryont Pharmaceuticals)
Blackbryont Pharmaceuticals Private Limited is the primary company behind Black Bryont Pharmaceuticals. The board of Blackbryont Pharmaceuticals Private Limited currently have 7 directors; the longest-serving is Sugunan Mathilakath, appointed in 2009. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sugunan Mathilakath DIN 02764773 | Director | 30 Sep 2009 | 17 yrs | Blackbryont Pharmaceuticals Private Limited |
| Ravindran Thekkedath DIN 00910194 | Director | 30 Sep 2009 | 17 yrs | Blackbryont Pharmaceuticals Private Limited |
| Shibu Kurian DIN 06515877 | Additional Director | 01 Apr 2013 | 13 yrs 6 mo | Blackbryont Pharmaceuticals Private Limited |
| Jayagopal Narayanan DIN 06519625 | Managing Director | 01 Apr 2013 | 13 yrs 6 mo | Blackbryont Pharmaceuticals Private Limited |
| Sivasankara Menon Biju DIN 06894040 | Additional Director | 01 Jun 2014 | 12 yrs 4 mo | Blackbryont Pharmaceuticals Private Limited |
| Sivadas Gopi DIN 08021511 | Director | 13 Dec 2017 | 8 yrs 10 mo | Blackbryont Pharmaceuticals Private Limited |
| Manoj Valiya Parakkatt DIN 08021518 | Director | 13 Dec 2017 | 8 yrs 10 mo | Blackbryont Pharmaceuticals Private Limited |
Financials of Black Bryont Pharmaceuticals
Figures of Blackbryont Pharmaceuticals Private Limited, the primary company behind Black Bryont Pharmaceuticals, for FY 2025. Revenue was ₹1.57 Cr (-3% year on year). Net profit was ₹10,378 (0% margin). EBITDA was ₹8.8 Lakh (6% margin). Revenue has grown at a compounded annual rate of +10% over three years and +6% over five years.
- ₹1.57 CrRevenue · FY 2025 · -3% YoY
- ₹10,378Net profit · 0% margin
- ₹8.8 LakhEBITDA · 6% margin
- ₹26 LakhPaid-up capital
- +10%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Blackbryont Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Black Bryont Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Black Bryont Pharmaceuticals
The primary company behind Black Bryont Pharmaceuticals, Blackbryont Pharmaceuticals Private Limited, reported revenue of βΉ1.57 Cr for FY 2025, down 3% year on year.
Quality and affordable pharmaceuticals are provided by Black Bryont Pharmaceuticals to enrich lives, focusing on branded generics for specialties like orthopedics, gynecology, and pediatrics. The company is recognized for its social responsibility in easing sufferings through affordable options and partnerships in healthcare. Achievements include serving over 1 lakh customers with expert pharmacies and more than 10 years of managerial expertise, while emphasizing fast delivery and reliable medicine supply. Operations are based in Kochi, India, with a commitment to collaboration among healthcare professionals.
Black Bryont Pharmaceuticals offers Branded Generics and Medicine Distribution Services.
Black Bryont Pharmaceuticals operates through Blackbryont Pharmaceuticals Private Limited.
The legal entities of Black Bryont Pharmaceuticals currently have 7 directors, including Sivasankara Menon Biju, Sugunan Mathilakath, Ravindran Thekkedath and others.
